Theratechnologies to Present at Upcoming Investor Conferences on October 29 and November 10, 2020

Rhea-AI Summary

MONTREAL, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (THTX) announced participation in several upcoming virtual investor conferences. Management will be at B. Riley Securities' Liver Disease Therapeutics Day on October 29, 2020, featuring a panel with Dr. Christian Marsolais. Additionally, Paul Levesque will present at the 29th Annual Credit Suisse Healthcare Conference on November 10, 2020, at 8:45 a.m. ET. Webcast details will be available on the company's website one day prior to each event.

News Market Reaction – THTX

-0.49%

-0.49% Session move

In the trading session that priced this news, THTX declined 0.49%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MONTREAL, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that management will be presenting at the following upcoming virtual investor conferences.

B. Riley Securities Liver Disease Therapeutics Day

• Thursday, October 29, 2020
• Panel discussion with Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer

29^th Annual Credit Suisse Healthcare Conference

• Tuesday, November 10, 2020, 8:45 a.m. ET
• Presentation by Paul Levesque, President and Chief Executive Officer

To access the virtual events, please visit the ‘News’ section of the Company’s website. The webcast details will be posted one day before the event date.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800

For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
lgibson@theratech.com 
617-356-1009

FAQ

When is Theratechnologies presenting at the B. Riley Securities Liver Disease Therapeutics Day?

Theratechnologies will present at the B. Riley Securities Liver Disease Therapeutics Day on October 29, 2020.

Who will represent Theratechnologies at the Credit Suisse Healthcare Conference?

Paul Levesque, the President and CEO, will represent Theratechnologies at the Credit Suisse Healthcare Conference on November 10, 2020.

How can I access the virtual events for Theratechnologies?

You can access the virtual events by visiting the 'News' section of Theratechnologies' website, where webcast details will be posted one day before each event.

What is the focus of Theratechnologies as a biopharmaceutical company?

Theratechnologies focuses on developing and commercializing innovative therapies to address unmet medical needs.

What is the stock symbol for Theratechnologies?

The stock symbol for Theratechnologies is THTX, listed on both TSX and NASDAQ.